Electromed (NYSEAMERICAN:ELMD) released its quarterly earnings results on Tuesday. The medical equipment provider reported $0.13 earnings per share (EPS) for the quarter, Morningstar.com reports. The firm had revenue of $8.60 million for the quarter.

Shares of ELMD stock opened at $5.61 on Friday. Electromed has a 1 year low of $4.66 and a 1 year high of $7.33.

Separately, TheStreet downgraded Electromed from a “b-” rating to a “c+” rating in a research note on Tuesday, June 25th.

A number of hedge funds have recently modified their holdings of ELMD. Northern Trust Corp raised its holdings in Electromed by 18.4% during the fourth quarter. Northern Trust Corp now owns 18,674 shares of the medical equipment provider’s stock worth $95,000 after purchasing an additional 2,900 shares during the last quarter. Susquehanna International Group LLP acquired a new position in Electromed during the second quarter worth $127,000. BlackRock Inc. raised its holdings in Electromed by 37.0% during the second quarter. BlackRock Inc. now owns 33,204 shares of the medical equipment provider’s stock worth $181,000 after purchasing an additional 8,965 shares during the last quarter. Punch & Associates Investment Management Inc. raised its holdings in Electromed by 98.9% during the first quarter. Punch & Associates Investment Management Inc. now owns 81,000 shares of the medical equipment provider’s stock worth $417,000 after purchasing an additional 40,285 shares during the last quarter. Finally, White Pine Capital LLC raised its holdings in shares of Electromed by 17.5% in the first quarter. White Pine Capital LLC now owns 90,765 shares of the medical equipment provider’s stock worth $467,000 after acquiring an additional 13,500 shares during the last quarter.

Electromed Company Profile

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality.

Featured Story: Why do earnings reports matter?

Earnings History for Electromed (NYSEAMERICAN:ELMD)

Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.